Tim Mosmann

Featured in: Favicon

Articles

Treatment of Relapsed/Refractory CLL Patients With PI3Kδ Inhibitor and Anti‐CD20 Antibody Rapidly Decreases Tumor Burden but Could Induce Resistance

Jan 3, 2025 | onlinelibrary.wiley.com | Jennifer Bruno |Andrea Baran |Paul Barr |Alyssa Williams |Sally Quataert |Tim Mosmann | +4 more

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →